Literature DB >> 7738878

Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.

M D Rawlins1.   

Abstract

Mesh:

Year:  1995        PMID: 7738878      PMCID: PMC5401160     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


× No keyword cloud information.
  42 in total

1.  Accuracy of hepatic adverse drug reaction reporting in one English health region.

Authors:  G P Aithal; M D Rawlins; C P Day
Journal:  BMJ       Date:  1999-12-11

2.  Spontaneous reporting--of what? Clinical concerns about drugs.

Authors:  I R Edwards
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

Review 3.  Assessment of therapeutic safety in systematic reviews: literature review.

Authors:  E Ernst; M H Pittler
Journal:  BMJ       Date:  2001-09-08

4.  Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting.

Authors:  C F Green; D R Mottram; P H Rowe; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

Review 5.  Adverse drug reactions: back to the future.

Authors:  Munir Pirmohamed; B Kevin Park
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

Review 6.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 7.  Advances in targeted therapy: safety of biological agents.

Authors:  E C Keystone
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

8.  Collecting and sharing information about harms.

Authors:  Munir Pirmohamed; Janet Darbyshire
Journal:  BMJ       Date:  2004-07-03

9.  Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Authors:  A Vallano; G Cereza; C Pedròs; A Agustí; I Danés; C Aguilera; J M Arnau
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

10.  A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme.

Authors:  Robert C G Bracchi; Jane Houghton; Fiona J Woods; Simon Thomas; Simon A Smail; Philip A Routledge
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.